Chemed (CHE) Financial Analysis & Valuation | Quarter Chart
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, ... more
Chemed Corporation provides hospice and palliative care services to patients through a network of ph... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $6.80B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Kevin J. McNamara |
| IPO Date | 1973-05-03 | CAGR | 4.9% |
| Employees | 15,811 | Website | www.chemed.com |
| Div. Yield | 3.74% | Payout Ratio | 12% |
| Buy Back Yield | 80.26% | Total Yield | 84% |
CHE chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $6.15B | P/E | 24.07 | Forward P/E | 20.06 | PEG | 18.33 |
| P/S | 0.31 | P/B | 0.96 | P/CF | 2.07 | P/FCF | 2.47 |
| Sales | $2.60B | Sales 1Y | 3.31% | Sales 3Y | 18.65% | Sales 5Y | 22.34% |
| EPS | $21.61 | EPS 1Y | 2.31% | EPS 3Y | 32.8% | EPS 5Y | 6.98% |
| Sales QoQ | 2.39% | EPS QoQ | 5.77% | Sales QoQ Avg | 2.13% | EPS QoQ Avg | 10.52% |
| Gross Margin | 30.44% | Operating Margin | 13.46% | Profit Margin | 10.6% | ROCE | 27.72% |
| ROA | 17% | ROE | 29% | Altman Z Score | 10.5 | Piotroski Score | 7 |
| Current Ratio | 0.91 | Quick Ratio | 0.89 | Cash Ratio | 0.13 | Op. CF Ratio | 0.27 |
| Debt/Equity | 0.35 | Debt/Assets | 0.19 | Lt Debt/Equity | 0.31 | Lt Debt/Cap. | 0.23 |
| Intrst Cov. | 72.4 | Inventory Turnover | 236.57 | Asset Turnover | 1.64 | Receivables Turnover | 13.76 |
| Enterprise Value | $6.15B | P/E Ratio | 24.07 |
| Forward P/E | 20.06 | PEG Ratio | 18.33 |
| P/S Ratio | 0.31 | P/B Ratio | 0.96 |
| P/CF Ratio | 2.07 | P/FCF Ratio | 2.47 |
| EPS | $21.61 | EPS Growth 1Y | 2.31% |
| EPS Growth 3Y | 32.8% | EPS Growth 5Y | 6.98% |
| Revenue Growth 1Y | 3.31% | Gross Margin | 30.44% |
| Operating Margin | 13.46% | Profit Margin | 10.6% |
| ROE | 29% | ROA | 17% |
| ROCE | 27.72% | Current Ratio | 0.91 |
| Quick Ratio | 0.89 | Cash Ratio | 0.13 |
| Debt/Equity | 0.35 | Interest Coverage | 72.4 |
| Altman Z Score | 10.5 | Piotroski Score | 7 |
Chemed (CHE) valuation & financials
Chemed (CHE) has a market capitalization of $6.80B and trades at a price-to-earnings ratio of 24.1. It operates in the Healthcare sector (Medical - Care Facilities).
Chemed's revenue grew +3.3% over the last year.
Chemed's next earnings report is scheduled for October 27, 2026 after market close (provider scheduled date); analysts estimate EPS of $6.39. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)